申请人:Ohkawa Shigenori
公开号:US20050080113A1
公开(公告)日:2005-04-14
The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.
本发明涉及一种用于预防或治疗疼痛的药剂,一种用于抑制成骨细胞活化的药剂,以及一种抑制成骨细胞形成的抑制剂,其中包含p38 MAP激酶抑制剂和/或TNF-α生产抑制剂。